Infectious Disease

Stanford global health expert Michele Barry shares essential facts.

Hantavirus is rare and unable to cause a global pandemic, says Jorge Salinas, medical director of infection prevention at Stanford Health Care.

The host-targeted approach of Shirit Einav’s lab could revolutionize antiviral development, creating broad-spectrum drugs resistant to viral mutation.

As warming temperatures spread dengue to new regions, Stanford researchers are using drones and artificial intelligence to hunt down hidden mosquito breeding sites.

A Stanford study reveals how testing and treatment strategies have the potential to cut HCV infections by nearly half among people who inject drugs, offering a cost-effective public health approach.

New Stanford-led research traces a direct line from extreme weather to a massive dengue outbreak in Peru. The findings serve as a warning – and the seed of a possible solution.

In light of a sustained surge in measles outbreaks last year, a pediatric infectious disease physician from Stanford Medicine shares key insights.

Holiday season was disrupted by a nasty flu bug for many around the country, and others aren’t out of the woods. Professor Yvonne Maldonado shares what you should know about “subclade K.”

A new study shows that the Epstein-Barr virus, carried by nearly everyone, may trigger lupus by turning immune cells against the body.

Stanford Health Policy researchers built a model to test whether AI could effectively manage disease spread between prisons and surrounding communities. The results were decisive.